Mankind Pharma inks in-licensing pact with China’s Chongqing Chenan Biopharmaceutical on two insulin analogues

Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical

Mankind Pharma has secured an exclusive agreement with Chongqing Chenan Biopharmaceutical. This partnership focuses on commercialising two insulin analogues for diabetes care. The deal will enhance Mankind Pharma's…